About

About PepGel Cellular Biomimicry At PepGel, we drive advances in cancer research and regenerative medicine built on next-generation synthetic hydrogel technologies. Unlike conventional 2D cultures or legacy artificial “3D” aggregates, Our innovative PGmatrix technology faithfully mimics the human extracellular matrix, unlocking new possibilities in cancer research and regenerative medicine through tumor organoids, transformative stem cell innovations and tissue regeneration. Our advanced solutions also propel progress in drug discovery, disease modeling, and in vivo drug delivery, accelerating the path from research to therapy. The PepGel portfolio encompasses four core product lines: PGmatrix 3D Cells, PGmatrix Stem-X, PGmatrix Bioink, and PGmatrix Injection. Complementing these product lines, we also provide custom hydrogel formulations, hiPSC-derived somatic cells, and advanced 3D tumor and organoid models for precise drug efficacy and toxicity testing and regenerative medicine. We move health forward, inspired by you.